0001225208-23-001909.txt : 20230214
0001225208-23-001909.hdr.sgml : 20230214
20230214163704
ACCESSION NUMBER: 0001225208-23-001909
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230210
FILED AS OF DATE: 20230214
DATE AS OF CHANGE: 20230214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wengel Kathryn E
CENTRAL INDEX KEY: 0001745955
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-03215
FILM NUMBER: 23630450
MAIL ADDRESS:
STREET 1: JOHNSON & JOHNSON
STREET 2: ONE JOHNSON & JOHNSON PLAZA
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JOHNSON & JOHNSON
CENTRAL INDEX KEY: 0000200406
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221024240
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 0101
BUSINESS ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
BUSINESS PHONE: 732-524-2455
MAIL ADDRESS:
STREET 1: ONE JOHNSON & JOHNSON PLZ
CITY: NEW BRUNSWICK
STATE: NJ
ZIP: 08933
4
1
doc4.xml
X0306
4
2023-02-10
0000200406
JOHNSON & JOHNSON
JNJ
0001745955
Wengel Kathryn E
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK
NJ
08933
1
EVP, Chief TO and Risk Officer
Common Stock
2023-02-10
4
M
0
1807.0000
0.0000
A
73117.8735
D
Common Stock
2023-02-10
4
F
0
667.0000
162.0800
D
72450.8735
D
Common Stock
54.0000
I
By 401k
Common Stock
281.0000
I
By ESOP
Restricted Share Units
2023-02-10
4
M
0
1807.0000
0.0000
D
2023-02-10
Common Stock
1807.0000
0.0000
D
Restricted Share Units awarded under Long-Term Incentive Plan on February 10, 2020 with a three year vesting period. The Restricted Share Units converted into shares of Common Stock on a one-for-one basis upon vesting.
Shares withheld for payment of taxes upon vesting of Restricted Share Units.
Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2023).
Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2023).
Raavi K. Deol, as attorney-in-fact for Kathryn E. Wengel
2023-02-14